Physician profile
Ali Ghomi
NPI 1639196520
$3,456.22
in general payments reported to CMS, 2019-2025
22 companies · $51.06 in 2025
The $51.06 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $612 · 2020: $397 · 2021: $263 · 2022: $565 · 2023: $1,467 · 2024: $101 · 2025: $51.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $613 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500 · Gift: $405 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $613.49 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
| Gift | $405.00 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,603.77 | 2019-2023 | Da Vinci Sp, Da Vinci Surgical System |
| Coloplast Corp | $366.16 | 2019-2023 | Altis |
| Caldera Medical, INC | $314.72 | 2020-2023 | Desara |
| Astellas Pharma US INC | $263.90 | 2019-2023 | |
| Abbvie INC. | $183.72 | 2019-2020 | |
| Smith+Nephew, INC. | $136.52 | 2019-2023 | Collagenase Santyl |
| Pfizer INC. | $87.67 | 2019-2021 | |
| Boston Scientific Corporation | $81.34 | 2023-2024 | |
| Avanos Medical | $72.47 | 2019 | |
| Lsi Solutions INC | $60.00 | 2019 | |
| Merck Sharp & Dohme LLC | $54.77 | 2019-2020 | |
| Axonics, INC. | $43.57 | 2023-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $36.46 | 2025 | Gemtesa |
| Baxter Healthcare | $23.16 | 2019 | |
| Coopersurgical, INC. | $21.80 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $18.29 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $17.60 | 2024 | |
| Hologic Sales and Service, LLC | $16.66 | 2024 | Myosure Tissue Removal Device |
| Provepharm INC. | $14.60 | 2025 | Bludigo |
| Becton, Dickinson and Company | $13.59 | 2019 | |
| Urovant Sciences INC | $13.48 | 2022 | |
| Duchesnay USA Incorporated | $11.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Ghomi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.